Minor Histocompatibility Antigens
- Minor Histocompatibility Antigens
- Accession Number
Allelic alloantigens often responsible for weak graft rejection in cases when (major) histocompatibility has been established by standard tests. In the mouse they are coded by more than 500 genes at up to 30 minor histocompatibility loci. The most well-known minor histocompatibility antigen in mammals is the H-Y antigen.
Drug Drug Description Nelipepimut-S Investigated for use/treatment in prostate cancer and breast cancer.
- Drugs & Drug Targets
Drug Target Type Nelipepimut-S HLA class I histocompatibility antigen, A-2 alpha chain target Nelipepimut-S HLA class I histocompatibility antigen, A-3 alpha chain target